Joshua Kashanirokh
Rheumatology · North Hollywood, CANPI 1003562232
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.9% of the total across 592 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 21.0% — the pattern of someone who eats at a lot of different presentations.
Across 592 payments — averaging $21.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Amgen$2K
- GSK$1K
- Johnson & Johnson$1K
- Mallinckrodt Hospital Products Inc.$847
- AstraZeneca$844
- plus $3K from 26 others
What the payments were for
- Food & beverage$12,24696%
- Education$5234%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 148 | $2,682 |
| Amgen | 132 | $2,431 |
| GSK | 63 | $1,284 |
| Johnson & Johnson | 40 | $1,211 |
| Mallinckrodt Hospital Products Inc. | 33 | $847 |
| AstraZeneca(2 entities) | 36 | $844 |
| UCB, Inc. | 28 | $629 |
| Lilly USA, LLC | 23 | $594 |
| Boehringer Ingelheim | 17 | $509 |
| Pfizer | 8 | $179 |
| Novartis | 8 | $178 |
| Exact Sciences | 7 | $172 |
| Teleflex LLC | 9 | $156 |
| Shield Therapeutics Inc | 5 | $125 |
| Octapharma USA, Inc. | 4 | $120 |
| Aurinia Pharma U.S., Inc. | 4 | $105 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $85 |
| Sanofi | 2 | $77 |
| Alvogen Inc | 3 | $74 |
| Scilex Pharmaceuticals Inc. | 3 | $65 |
| Sumitomo Pharma America, Inc. | 2 | $57 |
| Genentech USA, Inc. | 3 | $56 |
| ANI Pharmaceuticals, Inc. | 2 | $43 |
| Novo Nordisk | 2 | $43 |
| Fresenius Kabi USA, LLC | 1 | $31 |
| Invivyd Inc | 1 | $31 |
| Radius Health, Inc. | 2 | $29 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $28 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $25 |
| Merck | 1 | $20 |
| Kyowa Kirin, Inc. | 1 | $19 |
| Organon | 1 | $19 |
How this compares
$12,769 in reported general payments places this provider in the 75th percentile of 808 rheumatology providers in California.
Other rheumatology in North Hollywood
- Sudhakar TumuluriSan Francisco$2.8M
- Ara DikranianSan Diego$2.2M
- Orrin TroumSanta Monica$1.8M
- Robin DoreTustin$1.5M
- Samy MetyasCovina$1.3M
- Rhonda LambertSan Mateo$1.1M
- William ShielMission Viejo$924K
- Mark BoriginiDowney$920K
- Adam KreitenbergTarzana$863K
- Roger KornuTustin$802K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.